Updated on August 2, 2021 at 6:19 pm
NBCUniversal, Inc.
As cases of COVID-19 continue to rise, so does the use of experimental therapies.
Scientists now say they ve proved monoclonal antibodies can help keep some COVID-19 sufferers from becoming hospitalized. This is a game-changer, said principal investigator at Baylor Scott & White Research Institute Dr. Robert Gottlieb, But a lot of people still don t know about it.
Dr. Gottlieb has been leading the health care system s clinical trials involving synthetic monoclonal antibodies, explained on this U.S. Health and Human Services website.
After months of clinical trials, Gottlieb and his colleagues published this study just a few weeks ago.